Skip to main content

Teva Oncology

2022 Breast Cancer Guide to Patient Support Services

Teva Oncology Support Services

Teva CORE
888-587-3263
Teva Cares
877-237-4881

Teva Oncology offers the Comprehensive Oncology Reimbursement Expertise (CORE) program and the Teva Cares Foundation Patient Assistance Program to help patients while taking a Teva Oncology treatment (Table).

Teva CORE

The Teva CORE program helps eligible patients, their caregivers, and healthcare professionals navigate the reimbursement process through a range of services, including benefit verification, coverage determination, prior authorizations, letters of medical necessity, and referrals to the Teva Cares Foundation.

For patients prescribed Granix, Herzuma, and Truxima, Teva CORE offers a Patient Savings Program. Patients may be eligible for this if they:

  • Are at least 18 years of age
  • Have commercial insurance
  • Do not participate in Medicare, Medicaid, or other government insurance program.

Click here to enroll your patient in the Teva CORE program.

Teva Cares Foundation Patient Assistance Program

If your patient is uninsured or underinsured, they may be eligible to receive their prescribed Teva medication at no cost. Patients must meet certain financial and insurance coverage criteria to be eligible. Patient Assistance Program applications are available online.

TABLE Teva Breast Cancer Drug

Drug
Indications
Patient support programs

Drug
Herzuma (trastuzumab-pkrb)
Indications
Patient support programs

Herzuma (trastuzumab-pkrb) Indications

Treatment of HER2-overexpressing node-positive or -negative breast cancer, in combination with doxorubicin, cyclophosphamide, and either paclitaxel or docetaxel, or in combination with docetaxel and carboplatin; as monotherapy after anthracycline-based therapy; first-line treatment of HER2-overexpressing metastatic breast cancer, in combination with paclitaxel, or as monotherapy in patients who received ≥1 chemotherapy regimens for metastatic disease